Thursday, November 28, 2019

Prostate cancer: How new immunotherapy can help men with ‘very poor’ prognosis



PROSTATE CANCER is one of the most common forms of cancer in men, accounting for 44.4 percent of all cancers alongside lung, prostate and colorectal in 2018. A new immunotherapy drug has shown promise for prostate cancer sufferers in advanced stages of the disease.

from Daily Express :: Health Feed http://bit.ly/34uUQlN
via Buy Breast Actives
from Tumblr http://bit.ly/2Dof1WH

No comments:

Post a Comment